Hangzhou Alltest Biotech Co., Ltd. (SHA:688606)
China
· Delayed Price · Currency is CNY 54.76
+0.34 (0.62%)
Apr 29, 2026, 3:00 PM CST
Hangzhou Alltest Biotech Market Cap
Hangzhou Alltest Biotech has a market cap or net worth of 4.21 billion as of April 29, 2026. Its market cap has decreased by -31.25% in one year.
Market Cap
4.21B
Enterprise Value
1.98B
Revenue
898.20M
Ranking
n/a
PE Ratio
24.58
Stock Price
54.76
Market Cap Chart
Since March 25, 2021, Hangzhou Alltest Biotech's market cap has decreased from 9.38B to 4.21B, a decrease of -55.09%. That is a compound annual growth rate of -14.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 29, 2026 | 4.24B | -15.31% |
| Dec 31, 2025 | 5.00B | 1.91% |
| Dec 31, 2024 | 4.91B | -8.43% |
| Dec 29, 2023 | 5.36B | -2.86% |
| Dec 30, 2022 | 5.52B | -16.76% |
| Dec 31, 2021 | 6.63B | -29.28% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Zhejiang Gongdong Medical Technology | 4.14B |
| Well Lead Medical | 4.05B |
| Caina Technology | 3.89B |
| Shanghai Kindly Enterprise Development Group Co.,LTD. | 3.85B |
| SWS Hemodialysis Care | 5.05B |
| Chimin Health Management | 5.07B |
| Beijing Centergate Technologies (holding) | 3.54B |
| Jiangxi Sanxin Medtec | 5.18B |